Victoria group takes wind project to court, says public servants are next if successful.

As one group wages war against "renewables multinationals," farmers wishing to host transmission towers or wind turbines are caught in an increasingly nasty crossfire.

Fossil fuel lobbyists are flooding social media with ads, outgunning the minimal effort of the renewables industry, which is leaving the work to cash-strapped NGOs.

Fossil fuel lobbyists are flooding social media with ads, outgunning the minimal effort of the renewables industry, which is leaving the work to cash-strapped NGOs.

As one group wages war against "renewables multinationals," farmers wishing to host transmission towers or wind turbines are caught in an increasingly nasty crossfire.

By mixing different air layers, wind turbines can make surface air temperatures slightly warmer at night but they don't cause long term soil drying.

Industry insiders reject a persistent anecdote that 10% of solar panels arrive at major projects broken, but testers say they wouldn't be surprised.

Growatt's Guoxin Zhu allegedly offered $20,000 to Australian regulators. Here's what the saga reflects about the company and the regulator.

Exports are still "the biggest threat" to solar recycling feedstock supplies, without a stewardship scheme to make recycling more attractive.

Flagship pilot program to set up 100 sites around the country to collect used solar PV panels has been suspended, with no word on when it might resume.

Another oil and gas company collapse raises new concerns about who picks up massive clean up costs of decommissioned fields, and the renewables industry is watching closely.

YouTube video by Soundcraft Media

YouTube video by Soundcraft Media

YouTube video by Soundcraft Media

Cancer vaccines are an area that anyone who is anyone is getting into, but it's a field  led largely by academics, not-for–profits, and specialist researchers. So this week we go back to basics -...

YouTube video by Soundcraft Media

YouTube video by Soundcraft Media

YouTube video by Soundcraft Media

In some ways, cancer vaccines are a history of hype and hope, over success. But that hasn't stopped people from trying. In 2024, biotech CEOs are hoping that this time, it's different. Research houses...

YouTube video by Soundcraft Media

YouTube video by Soundcraft Media

Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within...

Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within...

YouTube video by Soundcraft Media

Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.But today the science has moved on, to therapy vacci...

Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.But today the science has moved on, to therapy vacci...

YouTube video by Soundcraft Media

Drone-deliveries of radioactive medicines and diagnostics to Australia's far-flung towns. Radiopharmaceuticals matched with genetic information to tailor precisely the right dose and isotope to a pers...

The rule of thumb in biotech is that it costs around $1 billion to bring a new therapy from lab to market. Protecting that investment is the patent system. But what if part of your product is not made...

The rule of thumb in biotech is that it costs around $1 billion to bring a new therapy from lab to market. Protecting that investment is the patent system. But what if part of your product is not made...

Can Australia create a mine to lab to bedside production line for radiopharmaceutical medicine? It has the reactor, biotechs and the hospitals to do that last two, and even has a growing pool of exper...

YouTube video by Soundcraft Media

The question we are dancing around in episode 3 of NUKED is whether locking down isotopes supply chains are really the only way to play the radiopharmaceutical game. We ask Clarity Pharmaceutical exec...

YouTube video by Soundcraft Media

In early 2023, one of the first two really big radiopharmaceutical drugs ran into a problem.  Novartis' prostate cancer therapy Pluvicto, released only the year before, was suddenly in short supply, s...

The radiopharmaceuticals sector is on a knife point. The scope of what nuclear medicine can do is exploding. But the radioisotopes that biotechs need to make those therapies are in very, very short su...

YouTube video by Soundcraft Media

Wearable kidneys. Organs on a chip. Xenotransplantation. The future is here.But is that the future people in biotech are truly looking to? Because the future that Certa Therapeutics CEO Darren Kelly i...

A weekly podcast exploring medicine 4.0 as we launch into the 21st Century of health. Join us as we highlight the science and investment case for the different diseases and conditions that life scienc...